Alpha Cognition Inc. Amortization of Intangible Assets
Alpha Cognition Inc. (ACOG) reported Amortization of Intangible Assets of $74.23 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-13
- Alpha Cognition Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $74.23K, a 1278.18% increase year-over-year.
- Alpha Cognition Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $5.39K, a 0.00% change year-over-year.
- Alpha Cognition Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $5.39K, a 72.74% decline year-over-year.
- Alpha Cognition Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $5.39K, a 72.74% decline year-over-year.
- Alpha Cognition Inc. amortization of intangible assets for fiscal 2025 was $21.55K, a 73.03% decline from fiscal 2024.
- Alpha Cognition Inc. amortization of intangible assets for fiscal 2024 was $79.88K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $74.23K 10-Q · filed 2026-08-13 | $79.62K 10-Q · filed 2026-08-13 | $85.00K derived: sum of 3 quarters · filed 2026-08-13 | $90.39K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $5.39K 10-Q · filed 2026-05-14 | $10.77K derived: sum of 2 quarters · filed 2026-05-14 | $16.16K derived: sum of 3 quarters · filed 2026-05-14 | $21.55K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $5.39K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $10.77K derived: sum of 2 quarters · filed 2026-03-31 | $16.16K derived: sum of 3 quarters · filed 2026-08-13 | $21.55K 10-K · filed 2026-03-31 |
| 2025-09-30 | $5.39K 10-Q · filed 2025-11-13 | $10.77K derived: sum of 2 quarters · filed 2026-08-13 | $16.16K 10-Q · filed 2025-11-13 | $35.92K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $5.39K 10-Q · filed 2026-08-13 | $10.77K 10-Q · filed 2026-08-13 | $30.53K derived: sum of 3 quarters · filed 2026-08-13 | $50.29K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $5.39K 10-Q · filed 2026-05-14 | $25.15K derived: sum of 2 quarters · filed 2026-05-14 | $44.91K derived: sum of 3 quarters · filed 2026-05-14 | $64.67K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $19.76K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $39.52K derived: sum of 2 quarters · filed 2026-03-31 | $59.28K derived: sum of 3 quarters · filed 2026-03-31 | $79.88K 10-K · filed 2026-03-31 |
| 2024-09-30 | $19.76K 10-Q · filed 2025-11-13 | $39.52K derived: sum of 2 quarters · filed 2025-11-13 | $60.12K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $19.76K 10-Q · filed 2025-08-14 | $40.35K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $20.59K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |